Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's drug
Pharma
AbbVie's Vyalev wins FDA nod in Parkinson's after 2 rejections
The 24-hour Parkinson's disease therapy crossed the FDA finish line after an initial rejection last year and another snub in June.
Zoey Becker
Oct 17, 2024 10:34am
Aspen Neuroscience levels up in-house cell therapy production
Oct 2, 2024 8:15am
Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 4:08pm
AbbVie's Duopa successor in Parkinson's rejected for 2nd time
Jun 25, 2024 9:47am
FDA shoots down Amneal's Parkinson's med
Jul 5, 2023 11:08am
Neurocrine gives up on Parkinson's drug Ongentys
May 3, 2023 10:55am
